Amoy Diagnostics (300685.SZ) some directors and senior executives intend to increase their shareholding in the company.
Amoy Diagnostics (300685.SZ) announced that Mr. Luo Jiemin, a director and the general manager of the company, intends to increase his shareholding in the company through the Shenzhen Stock Exchange trading system by way of centralized bidding within three months from the date of disclosure of the shareholding increase plan announcement, with the increase amount not less than RMB 5 million and not more than RMB 10 million.
Amoy Diagnostics (300685.SZ) announced that Mr. Luo Jiemin, a director and the general manager of the company, intends to increase his shareholding in the company through the Shenzhen Stock Exchange trading system by way of centralized bidding within three months from the date of disclosure of the shareholding increase plan announcement, with the increase amount not less than RMB 5 million and not more than RMB 10 million.
Mr. Ruan Li, a director and senior deputy general manager of the company, intends to increase his shareholding in the company through the Shenzhen Stock Exchange trading system by way of centralized bidding within three months from the date of disclosure of the shareholding increase plan announcement, with the increase amount not less than RMB 3 million and not more than RMB 6 million.
Ms. Chen Ying, the chief financial officer and board secretary of the company, intends to increase her shareholding in the company through the Shenzhen Stock Exchange trading system by way of centralized bidding within three months from the date of disclosure of the shareholding increase plan announcement, with the increase amount not less than RMB 4 million and not more than RMB 8 million.
Mr. Zheng Huibin, a deputy general manager of the company, intends to increase his shareholding in the company through the Shenzhen Stock Exchange trading system by way of centralized bidding within three months from the date of disclosure of the shareholding increase plan announcement, with the increase amount not less than RMB 3 million and not more than RMB 6 million.
Mr. Wang Hongyu, a deputy general manager of the company, intends to increase his shareholding in the company through the Shenzhen Stock Exchange trading system by way of centralized bidding within three months from the date of disclosure of the shareholding increase plan announcement, with the increase amount not less than RMB 3 million and not more than RMB 6 million.
Related Articles

WING ON CO (00289) repurchased 2,000 shares for HK$26,100 on September 16.

BEKE-W (02423) spent US$2.9982 million to repurchase 556,300 shares on September 15.

ESSEX BIO-TECH (01061) repurchased 25,000 shares for HK$51,000 on September 16.
WING ON CO (00289) repurchased 2,000 shares for HK$26,100 on September 16.

BEKE-W (02423) spent US$2.9982 million to repurchase 556,300 shares on September 15.

ESSEX BIO-TECH (01061) repurchased 25,000 shares for HK$51,000 on September 16.

RECOMMEND





